PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.\', \'Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD, USA.\', \'Laboratory of Pathology, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.\', \'Department of Obstetrics, Gynecology and Reproductive Sciences, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Tel-Aviv, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.15252/msb.20209628
?:doi
?:hasPublicationType
?:journal
  • Molecular systems biology
is ?:pmid of
?:pmid
?:pmid
  • 32729248
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 8.504
?:rankingScore_hIndex
  • 123
is ?:relation_isRelatedTo_publication of
?:title
  • In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all